{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:44:45Z","timestamp":1788839085632,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejphar.2024.176794","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T21:13:21Z","timestamp":1720041201000},"page":"176794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Effects of sacubitril-valsartan on aging-related cardiac dysfunction"],"prefix":"10.1016","volume":"978","author":[{"given":"Marialucia","family":"Telesca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Donniacuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Bellocchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Riemma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2214-7850","authenticated-orcid":false,"given":"Elena","family":"Mele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6936-4548","authenticated-orcid":false,"given":"Francesco","family":"Canonico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Cianflone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Torella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"D'Amario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-3968","authenticated-orcid":false,"given":"Giuseppe","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Liantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9140-5350","authenticated-orcid":false,"given":"Paola","family":"Imbrici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Cappetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6359-0974","authenticated-orcid":false,"given":"Konrad","family":"Urbanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liberato","family":"Berrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejphar.2024.176794_bib1","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3390\/cells8121558","article-title":"Osteopontin: a promising therapeutic target in cardiac fibrosis","volume":"8","author":"Abdelaziz","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176794_bib2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12933-021-01270-1","article-title":"Sacubitril\/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness","volume":"20","author":"Aroor","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176794_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2459\/JCM.0000000000001411","article-title":"Sacubitril\/valsartan reduces cardiac decompensation in heart failure with preserved ejection fraction: a meta-analysis","volume":"24","author":"Basile","year":"2023","journal-title":"J. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2024.176794_bib4","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2021.37","article-title":"Biomarkers in heart failure with preserved ejection fraction","volume":"8","author":"Bayes-Genis","year":"2022","journal-title":"Card. Fail. Rev."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176794_bib5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.118.034271","article-title":"Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction","volume":"138","author":"Beale","year":"2018","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ejphar.2024.176794_bib6","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.3390\/cells11213336","article-title":"Angiotensin II-induced signal transduction mechanisms for cardiac hypertrophy","volume":"11","author":"Bhullar","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.ejphar.2024.176794_bib7","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1152\/japplphysiol.01026.2003","article-title":"Echocardiographic assessment of age-associated changes in systolic and diastolic function of the female F344 rat heart","volume":"96","author":"Boluyt","year":"2004","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2024.176794_bib8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacc.2010.03.077","article-title":"Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction","volume":"56","author":"Borlaug","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176794_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00059-002-2354-y","article-title":"Cardiac fibrosis as a cause of diastolic dysfunction","volume":"27","author":"Burlew","year":"2002","journal-title":"Herz"},{"key":"10.1016\/j.ejphar.2024.176794_bib10","article-title":"Dipeptidyl peptidase 4 inhibition ameliorates chronic kidney disease in a model of salt-dependent hypertension","volume":"10","author":"Cappetta","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176794_bib11","doi-asserted-by":"crossref","first-page":"H315","DOI":"10.1152\/ajpheart.00142.2012","article-title":"Effect of healthy aging on left ventricular relaxation and diastolic suction","volume":"303","author":"Carrick-Ranson","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176794_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2217\/1745509X.4.1.37","article-title":"Role of the renin-angiotensin system in age-related sarcopenia and diastolic dysfunction","volume":"4","author":"Carter","year":"2008","journal-title":"Aging Health"},{"issue":"21","key":"10.1016\/j.ejphar.2024.176794_bib13","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.3390\/ijms21217927","article-title":"Statins stimulate new myocyte formation after myocardial infarction by activating growth and differentiation of the endogenous cardiac stem cells","volume":"21","author":"Cianflone","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ejphar.2024.176794_bib14","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jacbts.2020.07.006","article-title":"Differential effects of sacubitril\/valsartan on diastolic function in mice with obesity-related metabolic heart disease","volume":"5","author":"Croteau","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.ejphar.2024.176794_bib15","article-title":"GENERATOR HEART FAILURE DataMart: an integrated framework for heart failure research","volume":"10","author":"D'Amario","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"10.1016\/j.ejphar.2024.176794_bib16","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1089\/ars.2011.4179","article-title":"Cardiac aging: from molecular mechanisms to significance in human health and disease","volume":"16","author":"Dai","year":"2012","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2024.176794_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2016.04.168","article-title":"Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction","volume":"217","author":"De Angelis","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ejphar.2024.176794_bib18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/01.RES.0000163017.13772.3a","article-title":"CCL2\/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts","volume":"96","author":"Dewald","year":"2005","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176794_bib19","first-page":"219","article-title":"Heart failure in the elderly","volume":"18","author":"D\u00edez-Villanueva","year":"2021","journal-title":"J Geriatr Cardiol"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176794_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.108.845792","article-title":"The progression of hypertensive heart disease","volume":"123","author":"Drazner","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176794_bib21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.yjmcc.2004.12.015","article-title":"IL-1beta and TNF-alpha upregulate angiotensin II type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post-MI heart","volume":"38","author":"Gurantz","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176794_bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176794_bib23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00109-005-0718-5","article-title":"Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy","volume":"84","author":"Lieb","year":"2006","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"2","key":"10.1016\/j.ejphar.2024.176794_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10741-019-09837-7","article-title":"Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation?","volume":"25","author":"Mascolo","year":"2020","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ejphar.2024.176794_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106035","article-title":"Current and future therapeutic perspective in chronic heart failure","volume":"175","author":"Mascolo","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"36","key":"10.1016\/j.ejphar.2024.176794_bib26","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ejphar.2024.176794_bib27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCIMAGING.108.838367","article-title":"Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo","volume":"2","author":"Moreo","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176794_bib28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/cvr\/cvq351","article-title":"Electrical remodelling precedes heart failure in an endothelin-1-induced model of cardiomyopathy","volume":"89","author":"Mueller","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176794_bib29","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ehf2.13177","article-title":"Sacubitril\/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload","volume":"8","author":"Nord\u00e9n","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176794_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cardiores.2007.04.007","article-title":"Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice","volume":"75","author":"Oudit","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176794_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jchf.2019.08.020","article-title":"Healthy aging and cardiovascular function: invasive hemodynamics during rest and exercise in 104 healthy volunteers","volume":"8","author":"Pandey","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.ejphar.2024.176794_bib32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Paz","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176794_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69038-3","article-title":"Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity","volume":"10","author":"Piegari","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176794_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mayocpiqo.2018.12.006","article-title":"Rethinking endothelial dysfunction as a crucial target in fighting heart failure","volume":"3","author":"Premer","year":"2019","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"19","key":"10.1016\/j.ejphar.2024.176794_bib35","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1001\/jama.2021.15874","article-title":"Quality of life and exercise ability in heart failure with preserved ejection fraction: No time for therapeutic complacency","volume":"326","author":"Redfield","year":"2021","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.ejphar.2024.176794_bib36","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/CIRCULATIONAHA.105.541078","article-title":"Age- and gender-related ventricular-vascular stiffening: a community-based study","volume":"112","author":"Redfield","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176794_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115684","article-title":"MMP-2 and its implications on cardiac function and structure: interplay with inflammation in hypertension","volume":"215","author":"Ribeiro Vitorino","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176794_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.73.3.413","article-title":"Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype","volume":"73","author":"Sadoshima","year":"1993","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176794_bib39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1189\/jlb.0305127","article-title":"MCP-1\/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes","volume":"79","author":"Sakai","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2024.176794_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176170","article-title":"Sacubitril\/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction","volume":"961","author":"Shi","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176794_bib41","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/clc.23313","article-title":"Cardiac changes associated with vascular aging","volume":"43","author":"Singam","year":"2020","journal-title":"Clin. Cardiol."},{"issue":"17","key":"10.1016\/j.ejphar.2024.176794_bib42","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"PARAGON-HF investigators and committees. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176794_bib43","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.119.044586","article-title":"Sacubitril\/valsartan across the spectrum of ejection fraction in heart failure","volume":"141","author":"Solomon","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176794_bib44","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fendo.2020.00280","article-title":"Cardiomyocyte senescence and cellular communications within myocardial microenvironments","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.ejphar.2024.176794_bib45","doi-asserted-by":"crossref","first-page":"376","DOI":"10.14740\/cr1137","article-title":"Sacubitril\/valsartan inhibits cardiomyocyte hypertrophy in angiotensin II-induced hypertensive mice independent of a blood pressure-lowering effect","volume":"11","author":"Tashiro","year":"2020","journal-title":"Cardiol Res"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176794_bib46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/cancers16010053","article-title":"Initial phase of anthracycline cardiotoxicity involves cardiac fibroblasts activation and metabolic switch","volume":"16","author":"Telesca","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176794_bib47","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European society of Cardiology: cardiovascular disease statistics 2019","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ejphar.2024.176794_bib48","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1002\/ehf2.13124","article-title":"Heart failure in the last year: progress and perspective","volume":"7","author":"Tomasoni","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"7","key":"10.1016\/j.ejphar.2024.176794_bib49","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/metabo12070663","article-title":"Ranolazine counteracts strength impairment and oxidative stress in aged sarcopenic mice","volume":"12","author":"Torcinaro","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.ejphar.2024.176794_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106659","article-title":"Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome","volume":"188","author":"Urbanek","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176794_bib51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jacc.2019.11.003","article-title":"Prior heart failure hospitalization, clinical outcomes, and response to sacubitril\/valsartan compared with valsartan in HFpEF","volume":"75","author":"Vaduganathan","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176794_bib52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0735-1097(01)01377-8","article-title":"Nuclear factor kappa-B and the heart","volume":"38","author":"Valen","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ejphar.2024.176794_bib53","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jacbts.2017.07.013","article-title":"Murine models of heart failure with preserved ejection fraction: a \"fishing expedition\"","volume":"2","author":"Valero-Mu\u00f1oz","year":"2017","journal-title":"JACC Basic Transl Sci"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176794_bib54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11897-020-00458-y","article-title":"Angiotensin receptor-neprilysin inhibitors and the natriuretic peptide Axis","volume":"17","author":"Vasquez","year":"2020","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.ejphar.2024.176794_bib55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yjmcc.2015.02.004","article-title":"Age-associated pro-inflammatory remodeling and functional phenotype in the heart and large arteries","volume":"83","author":"Wang","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176794_bib56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13578-019-0348-1","article-title":"Angiotensin II receptor blocker LCZ696 attenuates cardiac remodeling through the inhibition of the ERK signaling pathway in mice with pregnancy-associated cardiomyopathy","volume":"9","author":"Wang","year":"2019","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176794_bib57","article-title":"VCAM1 expression in the myocardium is associated with the risk of heart failure and immune cell infiltration in myocardium","volume":"11","author":"Wang","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176794_bib58","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0008-6363(00)00101-2","article-title":"Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts","volume":"47","author":"Yamamoto","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2024.176794_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9570325","article-title":"Cardiac aging: from basic research to therapeutics","volume":"2021","author":"Yan","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176794_bib60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1042\/CS20060020","article-title":"Association study of ACE2 (angiotensin I-converting enzyme 2) gene polymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population","volume":"111","author":"Yang","year":"2006","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ejphar.2024.176794_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.600953","article-title":"Sacubitril\/valsartan reduces fibrosis and alleviates high-salt diet-induced HFpEF in rats","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924004825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924004825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T09:42:06Z","timestamp":1728380526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924004825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":61,"alternative-id":["S0014299924004825"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176794","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of sacubitril-valsartan on aging-related cardiac dysfunction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"176794"}}